Form 4: Agilon Health Executive Girish Venkatachaliah Reports Stock Transactions

Girish Venkatachaliah, Chief Technology Officer of Agilon Health, reports the vesting and settlement of performance-based restricted stock units (PSUs) and shares withheld for tax obligations.

Summary

• On March 14, 2025, Girish Venkatachaliah, the Chief Technology Officer of Agilon Health, had 9,429 performance-based restricted stock units (PSUs) vest, which were then settled for shares of common stock.
• The vesting of these PSUs was based on Agilon Health's revenue and adjusted EBITDA performance between January 1, 2022, and December 31, 2024, achieving 87% of the predetermined goals.
• Additionally, 3,311 shares of common stock were withheld by Agilon Health to cover income tax obligations related to the PSU settlement.
• Following these transactions, Venkatachaliah directly owns 155,120 shares of common stock, which includes restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it primarily reports transactions related to executive compensation. The 87% attainment of performance goals is mildly positive.

Positives

• The vesting of PSUs indicates that Agilon Health achieved a significant portion (87%) of its predetermined revenue and adjusted EBITDA goals over the three-year performance period.

Future Outlook

There is no specific future outlook provided in this document.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

• The vesting of PSUs and subsequent stock transactions may have a minor impact on shareholders due to the change in ownership.

Key Dates